Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000237323 is a pseudogene with sequence similarity to leukocyte immunoglobulin-like receptor A1 (LILRA1), a gene involved in immune system regulation and signaling in leukocytes. As a pseudogene, ENSG00000237323 does not encode a functional protein product and is not known to have a direct biological function; it is not considered a therapeutic target. Its functional paralog, LILRA1, is a receptor expressed on B cells and myeloid lineage cells, regulating immune activation through interaction with HLA class I molecules, but the pseudogene itself is not implicated in those activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on pseudogene similar to part of leukocyte-associated Ig-like receptor 1.